AbbVie Inc. (NYSE:ABBV) on Monday announced a voluntary agreement with the Trump administration to advance access and affordability further. AbbVie said it will provide low prices in Medicaid while pledging $100 billion in U.S.-based research and development and capital investments, including…
Continue reading...